CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1, Open-label, Multicenter, Dose-escalation Study of CK-301 Administered Intravenously as a Single Agent to Subjects With Advanced Cancers

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03212404
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:55.140126+00:00
Published At: 2025-02-03T00:00:00+00:00
Record Updated At: 2025-02-03
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Lung Neoplasms", "Carcinoma, Non-Small-Cell Lung", "Carcinoma, Small Cell", "Malignant Mesothelioma, Advanced", "Head and Neck Cancer", "Melanoma", "Merkel Cell Carcinoma", "Renal Cell Carcinoma", "Urothelial Carcinoma", "Classical Hodgkin Lymphoma", "Cutaneous Squamous Cell Carcinoma", "Non Hodgkin Lymphoma", "Endometrial Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-02-03"
protocolSection.identificationModule.nctId: "NCT03212404"
protocolSection.identificationModule.officialTitle: "A Phase 1, Open-label, Multicenter, Dose-escalation Study of CK-301 Administered Intravenously as a Single Agent to Subjects With Advanced Cancers"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.